Internal Medicine, Hematology & Oncology · Fountain Valley, CA
NPI
1063470391
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
11100 Warner Ave Ste 214
Fountain Valley, CA, 92708
Phone (714) 594-7820
Groups this clinician bills Medicare through
Medicare paid, 2024
$222K
13,277 services
Medicare patients, 2024
124
Average age 70
Drug cost, 2024
$2.0M
874 prescriptions
Company payments, 2025
$29K
From 63 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rufina Pamela Mae T Miel was code 99214 (office e&m - established), 159 times for 58 patients. In total Rufina Pamela Mae T Miel billed 13,277 services in 69 codes, and Medicare paid $222K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 159 | 58 | $103.73 | $16K |
| 36591 Vascular | Office | 67 | 16 | $24.26 | $1,625 |
| 96413 Chemotherapy Administration | Office | 40 | 13 | $120.30 | $4,812 |
| 96367 Intravenous Infusion, Hydration | Office | 36 | 14 | $25.02 | $901 |
| 99213 Office E&M - Established | Office | 24 | 17 | $67.04 | $1,609 |
| 96365 Intravenous Infusion, Hydration | Office | 20 | 14 | $51.27 | $1,025 |
| 99204 Office E&M - New | Office | 16 | 16 | $118.66 | $1,899 |
By year: 2022 $30K for 2,387 services; 2023 $366K for 16,466 services; 2024 $222K for 13,277 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rufina Pamela Mae T Miel prescribed most often to Medicare patients was Anastrozole, with 159 prescriptions and refills. In total Rufina Pamela Mae T Miel wrote 874 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 159 | 415 | 45 | $3,355 |
| Letrozole Generic | 47 | 117 | 12 | $1,057 |
| Ondansetron Odt Ondansetron | 41 | 41 | 23 | $807 |
| Hydroxyurea Generic | 34 | 82 | Under 11 | $821 |
| Orgovyx Relugolix | 33 | 33 | Under 11 | $90K |
| Alendronate Sodium Generic | 32 | 84 | Under 11 | $136 |
| Acyclovir Generic | 31 | 39 | Under 11 | $341 |
| Loperamide Loperamide Hcl | 29 | 29 | 20 | $214 |
| Morphine Sulfate Er Morphine Sulfate | 26 | 26 | Under 11 | $594 |
| Dexamethasone Generic | 25 | 25 | Under 11 | $381 |
| Xtandi Enzalutamide | 21 | 21 | Under 11 | $295K |
| Eliquis Apixaban | 19 | 27 | Under 11 | $15K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 17 | 33 | Under 11 | $95.47 |
| Pamidronate Disodium Generic | 15 | 41 | Under 11 | $588 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 14 | 14 | Under 11 | $108 |
Brand drugs: 231 claims; generic drugs: 643 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rufina Pamela Mae T Miel $29K ($29K in general payments such as food, travel and fees) from 63 companies. The largest payer was Avyxa Pharma, LLC with $4,549.
| Company | Payments | Amount |
|---|---|---|
| Avyxa Pharma, LLC | 7 | $4,549 |
| Genzyme Corporation SNY | 11 | $4,367 |
| Janssen Biotech, Inc. JNJ | 21 | $3,930 |
| GlaxoSmithKline, LLC. GSK | 11 | $2,774 |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $2,734 |
| Pfizer Inc. PFE | 13 | $1,787 |
| Novartis Pharmaceuticals Corporation NVS | 30 | $1,628 |
| Genmab U.S., Inc. GMAB | 1 | $1,575 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $372 |
| Novocure Inc. NVCR | 5 | $343 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.